201 related articles for article (PubMed ID: 17644205)
1. Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune responses to ovalbumin in mice following nasal administration.
Boonyo W; Junginger HE; Waranuch N; Polnok A; Pitaksuteepong T
J Control Release; 2007 Aug; 121(3):168-75. PubMed ID: 17644205
[TBL] [Abstract][Full Text] [Related]
2. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
Slütter B; Bal SM; Que I; Kaijzel E; Löwik C; Bouwstra J; Jiskoot W
Mol Pharm; 2010 Dec; 7(6):2207-15. PubMed ID: 21043518
[TBL] [Abstract][Full Text] [Related]
3. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
Hagenaars N; Verheul RJ; Mooren I; de Jong PH; Mastrobattista E; Glansbeek HL; Heldens JG; van den Bosch H; Hennink WE; Jiskoot W
J Control Release; 2009 Dec; 140(2):126-33. PubMed ID: 19712713
[TBL] [Abstract][Full Text] [Related]
4. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
Bal SM; Slütter B; Verheul R; Bouwstra JA; Jiskoot W
Eur J Pharm Sci; 2012 Mar; 45(4):475-81. PubMed ID: 22009113
[TBL] [Abstract][Full Text] [Related]
5. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
[TBL] [Abstract][Full Text] [Related]
6. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
Slütter B; Bal S; Keijzer C; Mallants R; Hagenaars N; Que I; Kaijzel E; van Eden W; Augustijns P; Löwik C; Bouwstra J; Broere F; Jiskoot W
Vaccine; 2010 Aug; 28(38):6282-91. PubMed ID: 20638455
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization.
Liu Q; Zhang C; Zheng X; Shao X; Zhang X; Zhang Q; Jiang X
Vaccine; 2014 May; 32(22):2582-90. PubMed ID: 24681230
[TBL] [Abstract][Full Text] [Related]
8. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation.
Bal SM; Slütter B; Jiskoot W; Bouwstra JA
Vaccine; 2011 May; 29(23):4025-32. PubMed ID: 21443959
[TBL] [Abstract][Full Text] [Related]
9. Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
Slütter B; Jiskoot W
J Control Release; 2010 Nov; 148(1):117-121. PubMed ID: 20600405
[TBL] [Abstract][Full Text] [Related]
10. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
11. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
Amidi M; Romeijn SG; Verhoef JC; Junginger HE; Bungener L; Huckriede A; Crommelin DJ; Jiskoot W
Vaccine; 2007 Jan; 25(1):144-53. PubMed ID: 16973248
[TBL] [Abstract][Full Text] [Related]
12. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
Bal SM; Slütter B; van Riet E; Kruithof AC; Ding Z; Kersten GF; Jiskoot W; Bouwstra JA
J Control Release; 2010 Mar; 142(3):374-83. PubMed ID: 19932723
[TBL] [Abstract][Full Text] [Related]
13. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system.
Hori M; Onishi H; Machida Y
Int J Pharm; 2005 Jun; 297(1-2):223-34. PubMed ID: 15885938
[TBL] [Abstract][Full Text] [Related]
15. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
[TBL] [Abstract][Full Text] [Related]
16. Role of trimethylated chitosan (TMC) in nasal residence time, local distribution and toxicity of an intranasal influenza vaccine.
Hagenaars N; Mania M; de Jong P; Que I; Nieuwland R; Slütter B; Glansbeek H; Heldens J; van den Bosch H; Löwik C; Kaijzel E; Mastrobattista E; Jiskoot W
J Control Release; 2010 May; 144(1):17-24. PubMed ID: 20100528
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
Tafaghodi M; Saluja V; Kersten GF; Kraan H; Slütter B; Amorij JP; Jiskoot W
Vaccine; 2012 Aug; 30(36):5341-8. PubMed ID: 22749834
[TBL] [Abstract][Full Text] [Related]
18. Nasal vaccination with r4M2e.HSP70c antigen encapsulated into N-trimethyl chitosan (TMC) nanoparticulate systems: Preparation and immunogenicity in a mouse model.
Dabaghian M; Latifi AM; Tebianian M; NajmiNejad H; Ebrahimi SM
Vaccine; 2018 May; 36(20):2886-2895. PubMed ID: 29627234
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant effect of ethanol extract of Semen Cuscutae on the immune responses to ovalbumin in mice.
Pan HJ; Sun HX; Pan YJ
J Ethnopharmacol; 2005 May; 99(1):99-103. PubMed ID: 15848026
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effectiveness and safety of chitosan derivatives as adjuvants for intranasal vaccines.
Kobayashi T; Fukushima K; Sannan T; Saito N; Takiguchi Y; Sato Y; Hasegawa H; Ishikawa K
Viral Immunol; 2013 Apr; 26(2):133-42. PubMed ID: 23509985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]